BPH Global (ASX:BP8) Debt-to-Asset : 0.50 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is BPH Global Debt-to-Asset?

BPH Global ASX:BP8 Debt-to-Asset is 0.50 as of Dec. 2025. The stock has 7 warning signs investors should review.

BPH Global's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2025 was A$0.58 Mil. BPH Global's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2025 was A$0.00 Mil. BPH Global's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2025 was A$1.15 Mil. BPH Global's debt to asset for the quarter that ended in Dec. 2025 was 0.50.


BPH Global  (ASX:BP8) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


BPH Global Debt-to-Asset Related Terms


BPH Global Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for BPH Global's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BPH Global Debt-to-Asset Chart

BPH Global Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.17 0.18 0.00 0.73 0.00

BPH Global Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.17 0.73 1.51 0.00 0.50

ASX:BP8 vs ZTS, UTHR: Debt-to-Asset Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, BPH Global's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BPH Global Debt-to-Asset vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BPH Global's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where BPH Global's Debt-to-Asset falls into.



BPH Global Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

BPH Global's Debt-to-Asset for the fiscal year that ended in Jun. 2025 is calculated as

BPH Global's Debt-to-Asset for the quarter that ended in Dec. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 0.50 mean?
BPH Global (ASX:BP8) has a Debt-to-Asset of 0.50 as of Dec. 2025. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on BPH Global and its competitors.
Is BPH Global's Debt-to-Asset too high?
BPH Global's current Debt-to-Asset is 0.50.
How does BPH Global's Debt-to-Asset compare to ZTS and UTHR?
BPH Global's Debt-to-Asset of 0.50 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Drug Manufacturers company?
A good Debt-to-Asset depends on the Drug Manufacturers industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on BPH Global and its competitors. BPH Global's current Debt-to-Asset is 0.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BPH Global stock overvalued right now?
BPH Global (ASX:BP8) has a current Debt-to-Asset of 0.50. The current Debt-to-Asset is 0.50. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For BPH Global (ASX:BP8), the current Debt-to-Asset is 0.50 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BPH Global Business Description

Other Exchanges USZ0:Germany
Address 96 Elizabeth Street, Block Arcade, Office 324, Level 3, Melbourne, VIC, AUS, 3000
BPH Global Ltd is a plant-focused biotechnology company with a focus on producing foods, health, and cosmetic products that deliver Traditional Chinese Medicine (TCM)-based health outcomes. It focuses on the research, development, production, and commercialization of TCM products, including bird's nest, seaweeds, and sea plants, which serve as sustainable plant-based protein sources and ingredients for food, nutrition, healthcare, cosmetics, and personal care industries. The company's geographical segment includes Australia, Indonesia, and China. The company's products comprise raw and processed bird's nest, sea grapes (Caulerpa lentillifera), and other seaweeds and sea plants.